“Breaking News This Week Advances, Innovations,
Post# of 630
https://thestreetreports.com/breaking-news-th...myzf-bult/
Halberd Corporation (OTC: HALB) On December 13, the company came into focus after it emerged that it had reached an agreement with CrodenHealth.com for the production, marketing, sales, and distribution of its low-dose naltrexone combo products across the world.
The product from Halberd is patented. Additionally, as per the terms of the agreement, CrodenHealth also held the right of first refusal pertaining to similar rights for products that may be produced in the future by Halberd. CrodenHealth enjoys a vast network of relationships in the industry and has dealt with massive pharmaceutical companies in the past.